Mankind Pharma

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,451.10",
    "chg": 43.5,
    "chgp": "1.81%",
    "dir": 1,
    "prev_price": "2,407.60",
    "mcapval": "101,188.35 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "May 14",
    "curr_time": "",
    "bse_nse_vol": "2.31 lacs",
    "exc_status": "Active",
    "traded_date": "May 14, 2026",
    "traded_date_str": "2026 05 14",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Ltd Technical Momentum Shifts Signal Mild Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-3986684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_technicaldot_3986684.png",
        "date": "2026-05-12 08:09:00",
        "description": "Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a strong recent price performance."
      },
      {
        "title": "Mankind Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Grounds",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-financial-grounds-3984933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_mojoScore_3984933.png",
        "date": "2026-05-11 08:23:42",
        "description": "Mankind Pharma Ltd has seen its investment rating upgraded from Sell to Hold as of 8 May 2026, reflecting a stabilisation in technical indicators and steady financial performance despite recent flat quarterly results. The mid-cap pharmaceutical company’s improved technical trend, solid management efficiency, and resilient sales growth underpin this revised outlook."
      },
      {
        "title": "Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3984817",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_technicaldot_3984817.png",
        "date": "2026-05-11 08:03:25",
        "description": "Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, supported by a blend of bullish and bearish signals across key technical indicators. The stock’s recent price action, combined with evolving momentum metrics, suggests a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Mankind Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mankind-pharma-ltd-fallingrising-3982549",
        "imagepath": "",
        "date": "2026-05-09 03:57:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Consistent Outperformance Against Benchmarks</strong></p>\n<p>Mankind Pharma’s recent price trajectory has significantly outpaced the broader market indices. Over the past week, the stock has surged by 8.04%, compared to a modest 0.54% gain in the Sensex. This trend extends over longer periods as well, with the stock appreciating 18.85% in the last month while the Sensex declined by 0.30%. Year-to-date, Mankind Pharma has delivered a 10.51% return, contrasting sharply with the Sensex’s 9.26% loss. Even on a one-year horizon, the stock has managed a positive 1.11% return, outperforming the Sensex’s 3.74% decline. These figures underscore the company’s resilience and appeal amid broader market volatility.</p>\n<p><strong>Strong Technical Indicators and Market Momentum</strong></p>\n<p>On the day ..."
      },
      {
        "title": "When is the next results date for Mankind Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mankind-pharma-ltd-3982496",
        "imagepath": "",
        "date": "2026-05-08 23:17:29",
        "description": "The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3977508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_mojoScore_3977508.png",
        "date": "2026-05-06 10:10:40",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3962105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_mojoScore_3962105.png",
        "date": "2026-04-25 10:10:25",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3961223.png",
        "date": "2026-04-24 15:01:15",
        "description": "Mankind Pharma Ltd has witnessed a notable 16.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.41% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market shows increased volume and participation, reflecting complex directional bets amid broader sector and market trends."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-3961084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3961084.png",
        "date": "2026-04-24 14:00:56",
        "description": "Mankind Pharma Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price decline of 0.64% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market reveals complex directional bets amid broader sector and index weakness."
      }
    ],
    "total": 514,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "19 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Ltd Technical Momentum Shifts Signal Mild Bullish Outlook

2026-05-12 08:09:00

Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a strong recent price performance.

Read full news article

Mankind Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Grounds

2026-05-11 08:23:42

Mankind Pharma Ltd has seen its investment rating upgraded from Sell to Hold as of 8 May 2026, reflecting a stabilisation in technical indicators and steady financial performance despite recent flat quarterly results. The mid-cap pharmaceutical company’s improved technical trend, solid management efficiency, and resilient sales growth underpin this revised outlook.

Read full news article

Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-11 08:03:25

Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, supported by a blend of bullish and bearish signals across key technical indicators. The stock’s recent price action, combined with evolving momentum metrics, suggests a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Mankind Pharma Ltd falling/rising?

2026-05-09 03:57:21

Consistent Outperformance Against Benchmarks

Mankind Pharma’s recent price trajectory has significantly outpaced the broader market indices. Over the past week, the stock has surged by 8.04%, compared to a modest 0.54% gain in the Sensex. This trend extends over longer periods as well, with the stock appreciating 18.85% in the last month while the Sensex declined by 0.30%. Year-to-date, Mankind Pharma has delivered a 10.51% return, contrasting sharply with the Sensex’s 9.26% loss. Even on a one-year horizon, the stock has managed a positive 1.11% return, outperforming the Sensex’s 3.74% decline. These figures underscore the company’s resilience and appeal amid broader market volatility.

Strong Technical Indicators and Market Momentum

On the day ...

Read full news article

When is the next results date for Mankind Pharma Ltd?

2026-05-08 23:17:29

The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026....

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-05-06 10:10:40

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-04-25 10:10:25

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 15:01:15

Mankind Pharma Ltd has witnessed a notable 16.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.41% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market shows increased volume and participation, reflecting complex directional bets amid broader sector and market trends.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:56

Mankind Pharma Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price decline of 0.64% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market reveals complex directional bets amid broader sector and index weakness.

Read full news article

View All News